ADVENT Post Approval Study

计划入组 228 人 · 首次发布于 2024 年 5 月 29 日

ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

计划入组 356 人 · 首次发布于 2024 年 7 月 30 日

Spectrophon LTD Glucometry Monitor Accuracy

计划入组 210 人 · 首次发布于 2017 年 12 月 2 日

Ross River Virus Vaccine(Ology Bioservices)

LTD-23

ERAPOL (Poliovirus infection), Biological E Ltd

Avid Bioservices

United States

Advent Claymore Convt Security & Income Fund

RESILIENCE GOVERNMENT SERVICES, INC.

United States

Northwest Biotherapeutics Completes Strategic Acquisition of Advent BioServices to Integrate Manufacturing Operations

Resonant Clinical Solutions Acquires Creapharm Bioservices to Expand Cryogenic Storage and Advanced-Therapy Capabilities

Cellipont Bioservices' Texas Facility Advances Six Cell Therapy Programs Toward IND Submission in 2026